Introduction
U.J. McMahan, Renée K. Margolis, David C. Turner, Gregory C. Sephel, Rebecca Tuttle, John L. Bixby(University of Miami), Sherry L. Rogers, Hynda K. Kleinman(National Institute of Dental and Craniofacial Research), Matthias Chiquet, Irene V. Pech, Naomi Kleitman, Michael J. Ignatius(Stanford University), Mary Bartlett Bunge, William Diller Matthew, Paul C. Letourneau(University of Minnesota), Bruce G. Wallace, Helen M. Buettner, Kevin J. Tomaselli, Beth A. Burrous, Richard U. Margolis(State University of New York), Alfred Sandrock(Biogen (United States)), Randall N. Pittman(University of Pennsylvania), Richard P. Bunge, Deborah E. Hall(University of California, San Francisco), Louis F. Reichardt(University of California, San Francisco), Karla M. Neugebauer(Yale University), Leonard A. Flier, Andy C. Dean
Cited by 0
Related Papers
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
|The Journal of Prevention of Alzheimer s Disease|2022|1.3k
Expression of apolipoprotein E during nerve degeneration and regeneration.
|Proceedings of the National Academy of Sciences|1986|568